Thank you for your interest in the Support Antibody Research To Help Stop COVID-19 Momentum campaign. This crowdfunding campaign has ended, but you can still support Dr. Parsons' antibody work by making a gift today!
COVID-19 is currently sweeping the globe, with more than 840,000 people affected worldwide as of March 31, 2020. The disease is bringing health complications, fear and even death. While current public health efforts of social distancing and increasing hygiene practices, including frequent hand washing and not touching your face, are helping flatten the curve of disease prevalence, there are no long-term answers for treating and preventing the disease.
The current pandemic makes a vaccine or other protective intervention, such as monoclonal antibodies, critical to prevent continued community spread and protect public health. A key strategy for preventing COVID-19 is to use antibodies against the SARS-CoV-2 virus, which causes COVID-19.
Emory researcher Matthew S. Parsons, PhD, and his research team are ready to move forward with their research to evaluate the antibodies humans generate following SARS-CoV-2 infection. The team will determine how the antibodies protect against infection and kill any infected cells, essential information necessary in the vaccine-development process and in the development of other pre-emptive measures.
Your donation will help Dr. Parsons and his research team immediately move forward with their antibody work, which will accelerate COVID-19 and other vaccine research. Your support can help end the devastation infectious diseases bring.
Dr. Parsons is an Assistant Professor in the Department of Pathology and Laboratory Medicine in the Emory University School of Medicine and a researcher at the Emory National Primate Research Center. He has more than a decade of experience studying the immunology of HIV infection, and his most recent research focused specifically on antibodies in preventing infection. Dr. Parsons’ expertise in antibody research is indispensable to the fight against COVID-19 and complements the strengths of his research collaborators at Emory University and across the United States and Canada.
You can learn more about Dr. Parsons here.